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Abstract
Purpose: Leukoaraiosis (LA), according to the latest classification, is white matter hyperintensity – morphological 
findings of small blood vessel disease of the brain. This radiological detection of small vessels disease is important 
because there are no technical possibilities to assess small vessels of the brain using computed tomography (CT) or 
magnetic resonance imaging (MRI) angiography. Our aim was to analysis the relationship between the extension of 
leukoaraiosis and severity of ischaemic stroke and brain atrophy.
Material and methods: We retrospectively analysed 77 head CT scans of patients admitted from the emergency room 
(ER) to the Radiology Department due to suspected stroke. We assessed the severity of leukoaraiosis using the van 
Swieten scale and brain atrophy by numerous linear measurements.
Results: Statistical analysis failed to demonstrate differences between LA1 and LA2 groups with regard to stroke 
severity in National Institutes of Health Stroke Scale (NIHSS) (p = 0.2159). There were no differences with regard 
to clinical severity of stroke between the study groups divided depending on the extent of brain atrophy. There were 
statistically significant differences with regard to the anterior horn width of the right and left lateral ventricle, poste-
rior horn width of the right and left lateral ventricle, distance between occipital horn of the left lateral ventricle and 
internal surface of the cranium and third ventricle width depending on the severity of leukoaraiosis.
Conclusions: The results of our studies present an association between the degree leukoaraiosis extension and brain 
atrophy, but no association between central nervous system tissue atrophy of extent of leukoaraiosis and ischaemic 
stroke severity.
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Introduction
The term leukoaraiosis (LA) refers to the changes in the 
white matter regions of the brain. These changes appear 
on computed tomography (CT) scans of the brain in hy-
podense lesions and result from poor blood flow, which 
is mostly symmetrical. Leukoaraiosis was presented by 
Hachiński in 1987, and it refers to computed tomography 
scans, which, together with usage of magnetic resonance 
imaging (MRI), were soon adopted to interpret MRI ap-
pearance of hypertension on T2-weighted images as well 
as FLAIR (fluid-attenuated inversion recovery). MRI is 
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currently the preferred method from CT because in MR 
the soft tissue is present in perivascular gliosis (mainly 
appearing in FLAIR), causing small blood pooling im-
ages to show up as hyperintense lesions. Micro damage 
of astrocytes, the main support cells often referred to as 
bridge structures of the brain, are apparent on a macro-
scopic scale in both CT as well as in in MRI. Astrocytes 
have the ability to seal the injury site by regulating forma-
tion and indirectly regulate inflammatory response; the 
whole process up close may look like a newly formatted 
membrane. 
Small blood vessel disease of the brain (SVD) has 
a high range of meaning with pathological processes, 
which affect the structure or function of venous and ar-
terial blood vessels in the brain. This term is widely used 
in radiology, clinical trials, and pathomorphology [1]. 
For years, authors have recommended in MRI the term 
white matter hyperintensity (WMH) of presumed vascu-
lar origin in order to distinguish changes associated with 
SVD from changes in multiple sclerosis (MS), leukodys-
trophies, and lots of fluid-filled spaces surrounding cer-
tain blood vessels, also known as a Virchow-Robin space 
[2-4]. The damage that causes the LA type depends on 
the topography on cerebrum vascularity and results from 
insufficient blood flow in the brain as a consequence of its 
location in deep structures of the brain supplied by lentic-
ulostriate arteries [3,5]. According to medical experts in 
this area there are several causes responsible for develop-
ing SVD-like arteriolosclerosis, sporadic and hereditary 
cerebral amyloid angiopathy, inherited or genetic small 
vessel diseases distinct from cerebral amyloid angiopathy, 
inflammatory and immunologically mediated small vessel 
diseases, and venous collagenosis [1].
Results from previous research show correlation be-
tween ongoing changes in SVD from magnetic resonance 
scans and post-mortem assessment. An intriguing fact 
is that in the case of pathomorphology analysis there is 
evidence of transient ischaemic attack, which is not ev-
ident in “standard” MR brain images (using measure-
ment of two different relaxation times – T1 and T2, as 
well as FLAIR, SWI, DWI sequences and ACD maps [6]). 
In addition to the above research data, the authors point 
out the changes in normally appearing white matter 
(NAWM) in which, in the microscopic image, we can ob-
serve astrocytic glial cells [4]. The above results confirm 
the “deceptive” character of small vessel disease of the brain. 
SVD is recognised by its complex clinical impact, from 
asymptomatic process (when the patient does not show 
neurological damage, but changes may or may not be evi-
dent in neuroimaging) to lacunar stroke, ischaemic stroke, 
and its less or more serious consequences, which results 
in a smaller or larger focal point of stroke with the clini-
cal indicator of neurological deficit [1,3,7]. According to 
the latest updated published articles and medical journals, 
10% to 30% of all ischaemic strokes are due to SVD [5]. 
Above all, SVD is without a doubt a cause of dementia – 
cognitive impairment, and motor and behavioural chang-
es [1,4,7]. 
Some authors emphasise the evident relationship 
between frequency and intensity of SVD with cerebral 
atrophy including general or focal atrophy, symmetrical 
or asymmetrical, or tissue selective (corpus callosum at-
rophy, hippocampus atrophy); however, brain atrophy is 
not typical for SVD [2,5,8]. Central atrophy is evident due 
to the extended size of the ventricular system and basal 
ganglia atrophy [2]. It is important to recognise that brain 
atrophy is a sign for ongoing vascular insufficiency and 
is without a doubt an indication for an advance ischae-
mia. Brain atrophy can be tested with different scales, for 
example the Pasquier scale, which provides a subjective 
evaluation because of its overall visual analysis. An alter-
native method to the Pasquier scale is adoption of a stand-
ardised rating scale and implementation of new upgraded 
computer software solutions, which are still unavailable 
in most clinics [9,10]. The connection between clinical 
image during acute ischaemic stroke and changes in the 
presence of leukoaraiosis using the van Swieten scale from 
progressive brain atrophy is crucial and interesting to cli-
nicians and researchers.
An important aspect is the fact that there are no tech-
nical possibilities – in contrast to large vessels – for the 
assessment of small vessels by use of MR or CT angiogra-
phy. There are available advanced techniques that are not 
used in convectional examination. Analysis of changes in 
the white matter of the brain allows indirect assessment of 
the small vessels of the central nervous system [1]. 
Due to the assessment of LA and atrophy treated as 
markers of the severity of ischaemic stroke, modification 
of primary prevention will be possible; therefore, the au-
thors undertake a thorough analysis of the correlation of 
the severity of ischaemic stroke with the extent of LA and 
the accompanying brain atrophy.
Material and methods
Head CT scans of 77 patients admitted from the emer-
gency room (ER) of Independent Public Clinical Hos-
pital No. 1 in Zabrze to the Neurology Department due 
to suspected stroke underwent retrospective radiological 
assessment. The study group consisted of 33 women and 
44 men aged 50-93 years (age range for women was 64-93 
years, for men: 50-92 years). 
Only studies fulfilling the following criteria were turn 
on to analysis: brain CTs of patients with suspected stroke, 
who were referred from the adult ER department; CT 
scans performed in accordance with the central nervous 
system imaging protocol to ability to assess using a ded-
icated diagnostic station that allows changes of image 
window width to be made. Leukoaraiosis was evaluated 
as grade 0 to 4. The ability to perform measurements of 
brain structures according to the scientific method. Assess 
stroke severity in the NIHSS scale.
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Exclusion criteria were as follows: incomplete CT ex-
amination or image artefacts (due to movement, foreign 
bodies, beam hardening); pathologies influencing density 
of the nervous system tissue, e.g. extensive brain stroke 
and pathologies causing mass effect, such as intracranial 
haemorrhage, tumours, inflammatory lesions (i.a. abscess-
es) or congenital defects associated with broadening of 
brain ventricles.
There are many scales that help with the assessment 
of hypodensity/hyperintensity changes in imaging. 
The van Swieten scale, for example, developed to test 
pathological regions in CT scans, and the Fazekas scale, 
used to compute the amount of white matter hyperintense 
lesions in MRI [11]. The van Swieten scale is used to test 
leukoaraiosis in CT scans by analysis of white matter hy-
podense lesions observed in the anterior and posterior 
areas in a specific examination slices: the slice through 
the choroid plexus, the slice through the cella media and 
the slice through the centrum semiovale. There is a three-
point scale: 0 – no changes, 1 – moderate changes in white 
matter, 2 – severe changes stretching out to subcortical 
structures. After computing points from the scale, this as-
sessment represents the entire white matter lesions with 
value of 0-4 [11,12] (Figure 1). 
CT scans were assessed for the severity of leukoaraio-
sis using the van Swieten scale. Patients were subsequently 
divided into two groups: LA1 and LA2, depending on the 
degree of advancement of lesions (patients with 0-2 points 
on van Swieten scale were included in LA1 group, while 
patients with 3 and 4 points comprised the LA2 group). 
Numerous linear measurements were performed in 
order to evaluate the morphology of fluid-filled spaces of 
the central nervous system, and the number of indexes 
were determined on their basis [10] (Table 1).
The degree of intensity in the above changes can be 
evaluated with many other clinical scales, for example the 
A B
Figure 1. Computed tomography brain images at the level of the ventricular system and semiovale centres show the hypodense areas of the type of leu-
koaraiosis – grade 4 on the scale by van Swieten (diffuse hypodense lesions are seen around the ventricles and in the semiovale centres)
Table 1. Indexes determined on the basis of linear measurements of the central nervous system 
Evans index Greatest dimension between anterior horns of lateral ventricles/maximal internal cranial diameter
Bicaudate index Shortest dimension between the heads of caudate nuclei/internal transverse diameter at the level of caudate nucleus head 
Bicaudal index Shortest dimension between the heads of caudate nuclei/maximum internal transverse cranial diameter
Bicaudal-frontal index Shortest dimension between the heads of caudate nuclei/maximum distance between anterior horns
Anterior horn width index The sum of anterior horn width/maximum internal cranial diameter 
Occipital horn distance 
index
Maximum spacing of occipital horns/maximum internal cranial transverse diameter
Occipital horn-to-cranium  
distance index
Mean distance from occipital horns to internal surface of the cranium at the same level/maximum cranial diameter
Occipital horn width ratio Mean width of occipital horns/maximum internal cranial diameter 
Schiersmann index Maximum external cranial diameter at the level of cella media/cella media width
Huckmann number Anterior horn width + smallest width of lateral ventricles
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NIHSS scale, modified Rankin Scale, and the Hachin-
ski Ischaemic Scale. The National Institutes of Health 
Stroke Scale (NIHSS) is a widely used method to measure 
stroke-related neurological deficit. The NIHSS is a 15-item 
neurological examination stroke scale that evaluates the 
level of consciousness, motor strength, ataxia, dysarthria, 
aphasia, extraocular movement, sensory loss, and ne-
glect. Severity of stroke in the NIHSS scale was assessed 
by a neurologist in all patients on admission. 
Statistical analysis was conducted using Statistica 12.5 
software. First, the sample distribution was examined 
using the Kolmogorov-Smirnov test. Student’s t-test was 
used to compare variables that followed normal distribu-
tion, while the U Mann-Whitney test was applied to var-
iables without normal distribution. The Loeven test was 
used to check for homogeneity of variance. Results were 
presented as means, standard deviations, medians, and 
quartiles. Chi2 test with Yates’s correction for continuity 
was used to compare group sizes. Results were presented 
as numbers and percentage values. The p-value of < 0.05 
was assumed as significant. 
Results
In the study group more severe leukoaraiosis-type le-
sions (grade 3 and 4 on the van Swieten scale) were noted 
among 42 patients (54.5%), more often in men (n = 25).
Statistical analysis failed to demonstrate differences 
between LA1 and LA2 groups with regard to stroke se-
verity in the NIHSS scale. 
There were no differences with regard to clinical sever-
ity of stroke between the study groups divided depending 
on the extent of brain atrophy.
In the group of studied patients, we demonstrated a re-
lationship between the extent of leukoaraiosis and brain 
atrophy as reflected by linear measurements of fluid-filled 
spaces of the central nervous system (CNS) and indexes 
calculated on the basis of those measurements (Figure 2). 
There were statistically significant differences with re-
gard to the anterior horn width of the right and left lateral 
ventricle (AHD, AHS), posterior horn width of the right 
and left lateral ventricle (OHD, OHS), distance between 
occipital horn of the left lateral ventricle and internal sur-
Figure 2. Axial and coronal slices of brain computed tomography show 
severity changes of the type of leukoaraiosis, and brain atrophy (prominent 
cerebral sulci and widening of the ventricular system)
A
C
B
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Table 2. Relationship between linear measurements of fluid-filled struc-
tures of the central nervous system and severity of leukoaraiosis in groups 
LA1 and LA2
Parameter Mean 
LA1
Standard
deviation
LA1
Mean 
LA2
Standard 
deviation  
LA2
p
AHD 8.26 2.25 9.81 2.16 0.0029
AHS 8.03 2.18 10.29 2.64 0.0001
OHD 14.51 4.14 16.45 4.07 0.0425
OHS 14.20 3.74 16.62 4.21 0.0101
DOHS 31.14 3.15 29.19 3.29 0.0099
III ventricle 8.66 2.82 10.83 2.68 0.0009
Table 3. Relationship between indexes describing the extent of brain atrophy and severity of leukoaraiosis in groups LA1 and LA2
Parameter Mean/*median 
LA1
Standard deviation/ 
*min, max LA1
Mean/*median 
LA2
Standard deviation/ 
*min, max LA2
p
Huckmann number 51.40 6.62 54.69 6.95 0.0379
Bicaudate index 0.15 0.03 0.18 0.03 0.0002
Bicaudal index 0.13 0.02 0.15 0.03 0.0002
Bicaudal-frontal (ventricular) index 0.51 0.08 0.59 0.08 0.0000
Anterior horn width index 0.06 0.01 0.08 0.02 0.0000
Occipital horn width ratio 0.11 0.03 0.13 0.03 0.0097
Occipital horn-to-cranium distance index 0.23 0.02 0.22 0.03 0.0482
Schiersmann index* 4.73* 3.05/14.10* 4.31* 3.18/5.92* 0.0140
*U Mann-Whitney test
face of the cranium (DOHS), and third ventricle width 
(III ventricle) depending on the severity of leukoaraiosis. 
The results are presented in Table 2. 
Mean values of indexes describing the degree of brain 
atrophy differed between LA1 and LA2 groups for such 
parameters as: Huckmann number, bicaudate index, bi-
caudal index, bicaudal-frontal (ventricular) index, anteri-
or horn width index, occipital horn width ratio, occipital 
horn-to-cranium distance index, and Schiersmann index. 
The results are shown in Table 3. 
Discussion
The relationship between leukoaraiosis and stroke re-
mains the subject of numerous studies and academic 
discussions. The presented results demonstrate that the 
extent of leukoaraiosis has no influence on the severity of 
stroke in the NIHSS scale in our study group. However, 
opinions concerning stroke severity and long-term prog-
nosis of patients with leukoaraiosis after ischaemic stroke 
vary. Some researchers consider LA an independent risk 
factor for deterioration of cognitive function after minor 
stroke (NIHSS ≤ 5) [13].
Results published in 2017 by Kannikar Kongbunkiat 
et al. are of particular importance in that regard, demon-
strating that both the presence and severity of leukoaraio-
sis influence the risk of development of symptomatic in-
tracranial haemorrhage and poor outcome of endovascular 
treatment, for both intra-arterial as well as intravenous 
thrombolysis in acute ischaemic stroke [14]. Although pre-
liminary results of a study by Helenius and Henniger show 
a relationship between the extent of leukoaraiosis and vol-
ume of infarction as well as clinical severity of stroke in 
NIHSS scale, the authors emphasise the necessity of fur-
ther research to corroborate their findings [15].
We should remember that MRI is the best method to 
detect acute ischaemic stroke and to assess the time of its 
occurrence, but CT is still the “gold standard” for imag-
ing acute stroke due to its short time of examination, less 
sensitivity to movement artefacts than MRI, and the fact 
that metallic elements in the patient’s body are not a con-
traindication to the examination (which could happen in 
the case of MRI). Moreover, CT examination allows the 
exclusion of intracranial bleeding, which is a contraindi-
cation to thrombolytic therapy [2,16,17].
According to Professor Wardlaw et al. [2], MRI is 
a better tool for assessment of WMH, and it allows precise 
evaluation by the Fazekas scale. The Fazekas scale in MRI 
images is a four-point visual scale, which is used to assess 
the hyperintense lesions in periventricular and deep white 
matter. In the periventricular white matter region, grading 
is assigned as follows: 0 – absent, 1 – “caps” or pencil-thin 
lining, 2 – smooth “halo”, and 3 – irregular periventricular 
signal extending into the deep white matter. In deep white 
matter each region is also graded: 0 – absent, 1 – punctate 
foci, 2 – beginning confluence, and 3 – large confluence 
areas [11,12].
The limitation of CT is the fact that both the infarction 
(areas of cytotoxic cerebral oedema and stroke) and leu-
koaraiosis are hypodense areas. Although leukoaraiosis is 
usually symmetrical, often in the context of a large hemi-
spheric stroke, its assessment may not be accurate enough.
Taking available literature data into consideration, it 
may be concluded that brain atrophy can be considered 
a biomarker for small vessel disease [8], while general 
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brain atrophy may be treated as a marker of SVD pro-
gression [5,7]. 
Our results support these relationships with respect 
to central atrophy reflected by widening of the ventricu-
lar system, especially the third ventricle. In the presented 
results the authors demonstrated an association between 
the severity of leukoaraiosis and brain atrophy, i.e. pa-
tients with more advanced LA lesions were characterised 
by more extensive nervous tissue atrophy. In their study, 
Moretti et al. showed an association between corpus callo-
sum atrophy (in particular: genu of corpus callosum) and 
gait disturbances among patients with leukoaraiosis [18]. 
The results of a study by Lambert et al. published in 2016 
demonstrated a relationship between WMH progression 
and brain atrophy in medial-frontal, orbito-frontal, pari-
etal, and occipital regions [3]. 
The presented research has some limitations – the 
MR examination performed in the examined patients 
would allow a more accurate evaluation of the ischaemic 
focus/foci and coexisting white matter hyperintensities. 
Extending the research with advanced diffusion tech-
niques – IVIM (Intravoxel incoherent motion) in an 
ultra-high 7T field MR devices – would allow more ac-
curate assessment of cerebral perfusion [19,20]. The use 
of modern computer software to assess the brain nervous 
tissue atrophy would allow a more precise (quantitative) 
assessment of cerebral atrophy.
Conclusions
The results of our studies present an association between 
the degree of leukoaraiosis extension and brain atrophy. 
However, no association was demonstrated between at-
rophy of central nervous system tissue or extent of leu-
koaraiosis and ischaemic stroke severity as measured on 
the NIHSS scale. 
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